BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parmar M, Grealish S, Henchcliffe C. The future of stem cell therapies for Parkinson disease. Nat Rev Neurosci 2020;21:103-15. [DOI: 10.1038/s41583-019-0257-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 88] [Article Influence: 28.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Qi Y, Zhao G, Zhang Z, Cao Y, Li Y, Xue J, Tang X. Expression profiles of microRNAs in midbrain of MPTP-treated mice determined by microRNA sequencing. Neurosci Lett 2022;788:136841. [PMID: 35988790 DOI: 10.1016/j.neulet.2022.136841] [Reference Citation Analysis]
2 Paredes-Espinosa MB, Paluh JL. Human stem cell-derived neurons and neural circuitry therapeutics: Next frontier in spinal cord injury repair. Exp Biol Med (Maywood) 2022;:15353702221114099. [PMID: 35974701 DOI: 10.1177/15353702221114099] [Reference Citation Analysis]
3 Liang L, Tian Y, Feng L, Wang C, Feng G, Stacey GN, Shyh-Chang N, Wu J, Hu B, Li W, Hao J, Wang L, Wang Y. Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs. Stem Cell Res Ther 2022;13:412. [PMID: 35964138 DOI: 10.1186/s13287-022-03104-7] [Reference Citation Analysis]
4 Parmar M. Targets for astrocyte-based treatments of Parkinson's disease (PD). Proc Natl Acad Sci U S A 2022;119:e2208876119. [PMID: 35858458 DOI: 10.1073/pnas.2208876119] [Reference Citation Analysis]
5 Chen B, Cui M, Wang Y, Shi P, Wang H, Wang F. Recent advances in cellular optogenetics for photomedicine. Adv Drug Deliv Rev 2022;188:114457. [PMID: 35843507 DOI: 10.1016/j.addr.2022.114457] [Reference Citation Analysis]
6 Ji Y, Hu C, Chen Z, Li Y, Dai J, Zhang J, Shu Q. Clinical trials of stem cell-based therapies for pediatric diseases: a comprehensive analysis of trials registered on ClinicalTrials.gov and the ICTRP portal site. Stem Cell Res Ther 2022;13:307. [PMID: 35841064 DOI: 10.1186/s13287-022-02973-2] [Reference Citation Analysis]
7 Yang X, Shao G, Zhang Y, Wang W, Qi Y, Han S, Li H. Applications of Magnetic Particle Imaging in Biomedicine: Advancements and Prospects. Front Physiol 2022;13:898426. [DOI: 10.3389/fphys.2022.898426] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Provin N, Giraud M. Differentiation of Pluripotent Stem Cells Into Thymic Epithelial Cells and Generation of Thymic Organoids: Applications for Therapeutic Strategies Against APECED. Front Immunol 2022;13:930963. [DOI: 10.3389/fimmu.2022.930963] [Reference Citation Analysis]
9 Thomas J, Martinez-Reza MF, Thorwirth M, Zarb Y, Conzelmann KK, Hauck SM, Grade S, Götz M. Excessive local host-graft connectivity in aging and amyloid-loaded brain. Sci Adv 2022;8:eabg9287. [PMID: 35687689 DOI: 10.1126/sciadv.abg9287] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Alekseenko Z, Dias JM, Adler AF, Kozhevnikova M, van Lunteren JA, Nolbrant S, Jeggari A, Vasylovska S, Yoshitake T, Kehr J, Carlén M, Alexeyenko A, Parmar M, Ericson J. Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery. Nat Commun 2022;13:3046. [PMID: 35650213 DOI: 10.1038/s41467-022-30777-8] [Reference Citation Analysis]
11 Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT. The future of stem cell therapies of Alzheimer's disease. Ageing Res Rev 2022;:101655. [PMID: 35660003 DOI: 10.1016/j.arr.2022.101655] [Reference Citation Analysis]
12 Vidović M, Rikalovic MG. Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches. Cells 2022;11:1732. [PMID: 35681426 DOI: 10.3390/cells11111732] [Reference Citation Analysis]
13 Li H, Jiang H, Li H, Li L, Yan Z, Feng J. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells. Mol Psychiatry 2022. [PMID: 35610351 DOI: 10.1038/s41380-022-01628-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jiang Z, Li N, Shao Q, Zhu D, Feng Y, Wang Y, Yu M, Ren L, Chen Q, Yang G. Light‐controlled scaffold‐ and serum‐free hard palatal‐derived mesenchymal stem cell aggregates for bone regeneration. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10334] [Reference Citation Analysis]
15 Chalazonitis A, Rao M, Sulzer D. Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson's disease. NPJ Parkinsons Dis 2022;8:50. [PMID: 35459867 DOI: 10.1038/s41531-022-00308-9] [Reference Citation Analysis]
16 Zhao Y, Wu J, Li D, Liu J, Chen W, Hou Z, Liu K, Jiang L, Chen X, Wang L, Hu B, Zong F, Wang Y, Wang Y. Human ESC-derived immunity- and matrix- regulatory cells ameliorated white matter damage and vascular cognitive impairment in rats subjected to chronic cerebral hypoperfusion. Cell Prolif 2022;:e13223. [PMID: 35437845 DOI: 10.1111/cpr.13223] [Reference Citation Analysis]
17 Giehrl-Schwab J, Giesert F, Rauser B, Lao CL, Hembach S, Lefort S, Ibarra IL, Koupourtidou C, Luecken MD, Truong DJ, Fischer-Sternjak J, Masserdotti G, Prakash N, Ninkovic J, Hölter SM, Vogt Weisenhorn DM, Theis FJ, Götz M, Wurst W. Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. EMBO Mol Med 2022;:e14797. [PMID: 35373464 DOI: 10.15252/emmm.202114797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wianny F, Dzahini K, Fifel K, Wilson CRE, Bernat A, Dolmazon V, Misery P, Lamy C, Giroud P, Cooper HM, Knoblauch K, Procyk E, Kennedy H, Savatier P, Dehay C, Vezoli J. Induced Cognitive Impairments Reversed by Grafts of Neural Precursors: A Longitudinal Study in a Macaque Model of Parkinson's Disease. Adv Sci (Weinh) 2022;9:e2103827. [PMID: 35137562 DOI: 10.1002/advs.202103827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lenglos C, Lin SJ, Zeighami Y, Baumeister TR, Carbonell F, Iturria-Medina Y. Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson's disease. Sci Rep 2022;12:5483. [PMID: 35361840 DOI: 10.1038/s41598-022-09506-0] [Reference Citation Analysis]
20 Wan X, Zhang D, Khan MA, Zheng S, Hu X, Zhang Q, Yang R, Xiong K. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement. Front Endocrinol 2022;13:859638. [DOI: 10.3389/fendo.2022.859638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Tran A, Yang P, Yang JYH, Ormerod JT. scREMOTE: Using multimodal single cell data to predict regulatory gene relationships and to build a computational cell reprogramming model. NAR Genomics and Bioinformatics 2022;4:lqac023. [DOI: 10.1093/nargab/lqac023] [Reference Citation Analysis]
22 Kim J, Jeon J, Song B, Lee N, Ko S, Cha Y, Leblanc P, Seo H, Kim KS. Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells. Nat Protoc 2022. [PMID: 35140411 DOI: 10.1038/s41596-021-00673-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Westphal M, Panza P, Kastenhuber E, Wehrle J, Driever W. Wnt/β-catenin signaling promotes neurogenesis in the diencephalospinal dopaminergic system of embryonic zebrafish. Sci Rep 2022;12:1030. [PMID: 35046434 DOI: 10.1038/s41598-022-04833-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nouri P, Zimmer A, Brüggemann S, Friedrich R, Kühn R, Prakash N. Generation of a NES-mScarlet Red Fluorescent Reporter Human iPSC Line for Live Cell Imaging and Flow Cytometric Analysis and Sorting Using CRISPR-Cas9-Mediated Gene Editing. Cells 2022;11:268. [DOI: 10.3390/cells11020268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ahmed M, Owens MJS, Toledo EM, Arenas E, Bradley M, Ffrench-Constant C. Combinatorial ECM Arrays Identify Cooperative Roles for Matricellular Proteins in Enhancing the Generation of TH+ Neurons From Human Pluripotent Cells. Front Cell Dev Biol 2021;9:755406. [PMID: 34926447 DOI: 10.3389/fcell.2021.755406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Shafiq M, Ali O, Han SB, Kim DH. Mechanobiological Strategies to Enhance Stem Cell Functionality for Regenerative Medicine and Tissue Engineering. Front Cell Dev Biol 2021;9:747398. [PMID: 34926444 DOI: 10.3389/fcell.2021.747398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bonam SR, Tranchant C, Muller S. Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease. Cells 2021;10:3547. [PMID: 34944054 DOI: 10.3390/cells10123547] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Aldrin-Kirk P, Åkerblom M, Cardoso T, Nolbrant S, Adler AF, Liu X, Heuer A, Davidsson M, Parmar M, Björklund T. A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants. Stem Cell Reports 2021:S2213-6711(21)00595-6. [PMID: 34971563 DOI: 10.1016/j.stemcr.2021.11.014] [Reference Citation Analysis]
29 Parmar M, Pereira CF. Reprogramming Stars #4: A Reprogramming Approach for Parkinson's Disease-An Interview with Dr. Malin Parmar. Cell Reprogram 2021;23:319-25. [PMID: 34889661 DOI: 10.1089/cell.2021.29049.mp] [Reference Citation Analysis]
30 Roshani M, Kiaie N, Aghdam RM. Biomaterials and stem cells as drug/gene-delivery vehicles for Parkinson's treatment: an update. Regen Med 2021;16:1057-72. [PMID: 34865515 DOI: 10.2217/rme-2021-0050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Ahmad J, Haider N, Khan MA, Md S, Alhakamy NA, Ghoneim MM, Alshehri S, Sarim Imam S, Ahmad MZ, Mishra A. Novel therapeutic interventions for combating Parkinson's disease and prospects of Nose-to-Brain drug delivery. Biochem Pharmacol 2022;195:114849. [PMID: 34808125 DOI: 10.1016/j.bcp.2021.114849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
32 Sun Y, Feng L, Liang L, Stacey GN, Wang C, Wang Y, Hu B. Neuronal cell-based medicines from pluripotent stem cells: Development, production, and preclinical assessment. Stem Cells Transl Med 2021;10 Suppl 2:S31-40. [PMID: 34724724 DOI: 10.1002/sctm.20-0522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Ferreira H, Amorim D, Lima AC, Pirraco RP, Costa-Pinto AR, Almeida R, Almeida A, Reis RL, Pinto-Ribeiro F, Neves NM. A biocompatible and injectable hydrogel to boost the efficacy of stem cells in neurodegenerative diseases treatment. Life Sci 2021;287:120108. [PMID: 34717909 DOI: 10.1016/j.lfs.2021.120108] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Lilienberg J, Hegyi Z, Szabó E, Hathy E, Málnási-Csizmadia A, Réthelyi JM, Apáti Á, Homolya L. Pharmacological Modulation of Neurite Outgrowth in Human Neural Progenitor Cells by Inhibiting Non-muscle Myosin II. Front Cell Dev Biol 2021;9:719636. [PMID: 34604221 DOI: 10.3389/fcell.2021.719636] [Reference Citation Analysis]
35 Gilbert G. Approaches to Optimize Stem Cell-Derived Cardiomyocyte Maturation and Function. Curr Stem Cell Rep 2021;7:140-60. [DOI: 10.1007/s40778-021-00197-3] [Reference Citation Analysis]
36 Qarin S, Howlett SK, Jones JL, Barker RA. The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease. Neuronal Signal 2021;5:NS20200083. [PMID: 34552761 DOI: 10.1042/NS20200083] [Reference Citation Analysis]
37 Tabet A, Antonini MJ, Sahasrabudhe A, Park J, Rosenfeld D, Koehler F, Yuk H, Hanson S, Stinson J, Stok M, Zhao X, Wang C, Anikeeva P. Modular Integration of Hydrogel Neural Interfaces. ACS Cent Sci 2021;7:1516-23. [PMID: 34584953 DOI: 10.1021/acscentsci.1c00592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Bidesi NSR, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM. The role of neuroimaging in Parkinson's disease. J Neurochem 2021;159:660-89. [PMID: 34532856 DOI: 10.1111/jnc.15516] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
39 Seutin V. Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough? Front Cell Neurosci 2021;15:715273. [PMID: 34483841 DOI: 10.3389/fncel.2021.715273] [Reference Citation Analysis]
40 Henchcliffe C, Sarva H. Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease. CNS Drugs. 2020;34:559-577. [PMID: 32472450 DOI: 10.1007/s40263-020-00727-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Jan A, Gonçalves NP, Vaegter CB, Jensen PH, Ferreira N. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses. Int J Mol Sci 2021;22:8338. [PMID: 34361100 DOI: 10.3390/ijms22158338] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
42 Santos García D, Blázquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, García Ruiz PJ, Grandas F, Kulisevsky J, López-Manzanares L, Martínez Castrillo JC, Mir P, Pagonabarraga J, Pérez-Errazquin F, Salom JM, Tijero B, Valldeoriola F, Yáñez R, Avilés A, Luquín MR. Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sci 2021;11:1027. [PMID: 34439646 DOI: 10.3390/brainsci11081027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Lu C, Han L, Wang J, Wan J, Song G, Rao J. Engineering of magnetic nanoparticles as magnetic particle imaging tracers. Chem Soc Rev 2021;50:8102-46. [PMID: 34047311 DOI: 10.1039/d0cs00260g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
44 Pearson TS, Gupta N, San Sebastian W, Imamura-Ching J, Viehoever A, Grijalvo-Perez A, Fay AJ, Seth N, Lundy SM, Seo Y, Pampaloni M, Hyland K, Smith E, de Oliveira Barbosa G, Heathcock JC, Minnema A, Lonser R, Elder JB, Leonard J, Larson P, Bankiewicz KS. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun 2021;12:4251. [PMID: 34253733 DOI: 10.1038/s41467-021-24524-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
45 Liebert A, Bicknell B, Laakso EL, Heller G, Jalilitabaei P, Tilley S, Mitrofanis J, Kiat H. Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study. BMC Neurol 2021;21:256. [PMID: 34215216 DOI: 10.1186/s12883-021-02248-y] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
46 Karimi A, Elmi M, Shiri Z, Baharvand H. Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson's disease: a systematic review protocol. Syst Rev 2021;10:188. [PMID: 34172098 DOI: 10.1186/s13643-021-01736-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Absalan F, Pasandi MS, Ghasemi Hamidabadi H, Saeednia S, Bojnordi MN, Zahiri M, Alizadeh R, Bagher Z. Matrigel enhances differentiation of human adipose tissue-derived stem cells into dopaminergic neuron. Neurosci Lett 2021;760:136070. [PMID: 34147538 DOI: 10.1016/j.neulet.2021.136070] [Reference Citation Analysis]
48 Ahmed N, Gandhi D, Melhem ER, Frenkel V. MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications. Front Neurol 2021;12:669449. [PMID: 34220679 DOI: 10.3389/fneur.2021.669449] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
49 Pütz SM, Kram J, Rauh E, Kaiser S, Toews R, Lueningschroer-Wang Y, Rieger D, Raabe T. Loss of p21-activated kinase Mbt/PAK4 causes Parkinson-like phenotypes in Drosophila. Dis Model Mech 2021;14:dmm047811. [PMID: 34125184 DOI: 10.1242/dmm.047811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Mohammadi MR, Rodriguez SM, Luong JC, Li S, Cao R, Alshetaiwi H, Lau H, Davtyan H, Jones MB, Jafari M, Kessenbrock K, Villalta SA, de Vos P, Zhao W, Lakey JRT. Exosome loaded immunomodulatory biomaterials alleviate local immune response in immunocompetent diabetic mice post islet xenotransplantation. Commun Biol 2021;4:685. [PMID: 34083739 DOI: 10.1038/s42003-021-02229-4] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
51 Bondarenko O, Saarma M. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain. Front Cell Neurosci 2021;15:682597. [PMID: 34149364 DOI: 10.3389/fncel.2021.682597] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
52 Kim TW, Piao J, Koo SY, Kriks S, Chung SY, Betel D, Socci ND, Choi SJ, Zabierowski S, Dubose BN, Hill EJ, Mosharov EV, Irion S, Tomishima MJ, Tabar V, Studer L. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell 2021;28:343-355.e5. [PMID: 33545081 DOI: 10.1016/j.stem.2021.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
53 Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L, Tomishima M, Tabar V. Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01. Cell Stem Cell 2021;28:217-229.e7. [PMID: 33545080 DOI: 10.1016/j.stem.2021.01.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
54 Lattanzi W, Ripoli C, Greco V, Barba M, Iavarone F, Minucci A, Urbani A, Grassi C, Parolini O. Basic and Preclinical Research for Personalized Medicine. J Pers Med 2021;11:354. [PMID: 33946634 DOI: 10.3390/jpm11050354] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Vallée A, Vallée JN, Lecarpentier Y. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation. Aging (Albany NY) 2021;13:10796-813. [PMID: 33848261 DOI: 10.18632/aging.202951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
56 Silva S, Almeida AJ, Vale N. Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 2021;13:508. [PMID: 33917696 DOI: 10.3390/pharmaceutics13040508] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 He S, Wang F, Yung KKL, Zhang S, Qu S. Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease. ACS Chem Neurosci 2021;12:1061-71. [PMID: 33769791 DOI: 10.1021/acschemneuro.1c00028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
58 Björklund A, Parmar M. Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair. J Parkinsons Dis 2021. [PMID: 33814467 DOI: 10.3233/JPD-212609] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Kuang W, Liu T, He F, Yu L, Wang Q, Yu C. Icariside II promotes the differentiation of human amniotic mesenchymal stem cells into dopaminergic neuron-like cells. In Vitro Cell Dev Biol Anim 2021;57:457-67. [PMID: 33721206 DOI: 10.1007/s11626-021-00556-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Tynecka M, Moniuszko M, Eljaszewicz A. Old Friends with Unexploited Perspectives: Current Advances in Mesenchymal Stem Cell-Based Therapies in Asthma. Stem Cell Rev Rep 2021;17:1323-42. [PMID: 33649900 DOI: 10.1007/s12015-021-10137-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ntetsika T, Papathoma PE, Markaki I. Novel targeted therapies for Parkinson's disease. Mol Med 2021;27:17. [PMID: 33632120 DOI: 10.1186/s10020-021-00279-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
62 Kambey PA, Kanwore K, Ayanlaja AA, Nadeem I, Du Y, Buberwa W, Liu W, Gao D. Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review. Front Aging Neurosci 2021;13:645583. [PMID: 33716718 DOI: 10.3389/fnagi.2021.645583] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
63 Corti S, Bonjean R, Legier T, Rattier D, Melon C, Salin P, Toso EA, Kyba M, Kerkerian-Le Goff L, Maina F, Dono R. Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation. Stem Cells Transl Med 2021;10:725-42. [PMID: 33528918 DOI: 10.1002/sctm.20-0177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Xiao Z, Lei T, Liu Y, Yang Y, Bi W, Du H. The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson's disease. Stem Cell Res Ther 2021;12:5. [PMID: 33407864 DOI: 10.1186/s13287-020-01957-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Katolikova NV, Malashicheva AB, Gainetdinov RR. Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice. Mol Biol 2020;54:827-39. [DOI: 10.1134/s0026893320060060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Carelli S, Giallongo T, Rey F, Barzaghini B, Zandrini T, Pulcinelli A, Nardomarino R, Cerullo G, Osellame R, Cereda C, Zuccotti GV, Raimondi MT. Neural precursors cells expanded in a 3D micro-engineered niche present enhanced therapeutic efficacy in vivo.Nanotheranostics. 2021;5:8-26. [PMID: 33391972 DOI: 10.7150/ntno.50633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ford E, Pearlman J, Ruan T, Manion J, Waller M, Neely GG, Caron L. Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.Cells. 2020;9. [PMID: 33233861 DOI: 10.3390/cells9112517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
68 Aliakbari F, Mohammad‐beigi H, Abbasi S, Rezaei‐ghaleh N, Lermyte F, Parsafar S, Becker S, Tafreshi AP, O'connor PB, Collingwood JF, Christiansen G, Sutherland DS, Jensen PH, Morshedi D, Otzen DE. Multiple Protective Roles of Nanoliposome‐Incorporated Baicalein against Alpha‐Synuclein Aggregates. Adv Funct Mater 2021;31:2007765. [DOI: 10.1002/adfm.202007765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Tarakad A, Jankovic J. Recent advances in understanding and treatment of Parkinson's disease. Fac Rev 2020;9:6. [PMID: 33659938 DOI: 10.12703/b/9-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
70 Sidorova YA, Saarma M. Can Growth Factors Cure Parkinson's Disease? Trends Pharmacol Sci 2020;41:909-22. [PMID: 33198924 DOI: 10.1016/j.tips.2020.09.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
71 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
72 Iqubal A, Iqubal MK, Khan A, Ali J, Baboota S, Haque SE. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective. CGT 2020;20:184-94. [DOI: 10.2174/1566523220999200716111502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
73 Asif A, García-López S, Heiskanen A, Martínez-Serrano A, Keller SS, Pereira MP, Emnéus J. Pyrolytic Carbon Nanograss Enhances Neurogenesis and Dopaminergic Differentiation of Human Midbrain Neural Stem Cells. Adv Healthc Mater 2020;9:e2001108. [PMID: 32902188 DOI: 10.1002/adhm.202001108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Kouroupi G, Antoniou N, Prodromidou K, Taoufik E, Matsas R. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification. Int J Mol Sci 2020;21:E7113. [PMID: 32993172 DOI: 10.3390/ijms21197113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
75 Fonseca AC, Melchels FPW, Ferreira MJS, Moxon SR, Potjewyd G, Dargaville TR, Kimber SJ, Domingos M. Emulating Human Tissues and Organs: A Bioprinting Perspective Toward Personalized Medicine. Chem Rev 2020;120:11128-74. [PMID: 32937071 DOI: 10.1021/acs.chemrev.0c00342] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
76 Muckom R, Bao X, Tran E, Chen E, Murugappan A, Dordick JS, Clark DS, Schaffer DV. High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates. Sci Adv 2020;6:eaaz1457. [PMID: 32821815 DOI: 10.1126/sciadv.aaz1457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Chung YG, Seay M, Elsworth JD, Redmond DE. Generation of Pluripotent Stem Cells Using Somatic Cell Nuclear Transfer and Induced Pluripotent Somatic Cells from African Green Monkeys. Stem Cells Dev 2020;29:1294-307. [PMID: 32715987 DOI: 10.1089/scd.2020.0059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Kim TW, Koo SY, Studer L. Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities. Front Cell Dev Biol 2020;8:729. [PMID: 32903681 DOI: 10.3389/fcell.2020.00729] [Cited by in Crossref: 19] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
79 Pukfukdee P, Banlunara W, Rutwaree T, Limcharoen B, Sawutdeechaikul P, Pattarakankul T, Sansureerungsikul T, Toprangkobsin P, Leelahavanichkul A, Panchaprateep R, Asawanonda P, Palaga T, Wanichwecharungruang S. Solid Composite Material for Delivering Viable Cells into Skin Tissues via Detachable Dissolvable Microneedles. ACS Appl Bio Mater 2020;3:4581-9. [PMID: 35025457 DOI: 10.1021/acsabm.0c00498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
80 Kobold S, Guhr A, Mah N, Bultjer N, Seltmann S, Seiler Wulczyn AEM, Stacey G, Jie H, Liu W, Löser P, Kurtz A. A Manually Curated Database on Clinical Studies Involving Cell Products Derived from Human Pluripotent Stem Cells. Stem Cell Reports 2020;15:546-55. [PMID: 32679065 DOI: 10.1016/j.stemcr.2020.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
81 Hegarty SV, Green HF, Niclis J, O'Keeffe GW, Sullivan AM. Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease. Front Neurosci 2020;14:515. [PMID: 32655345 DOI: 10.3389/fnins.2020.00515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Jankovic J, Okun MS, Kordower JH. Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease. Mov Disord 2020;35:1312-4. [DOI: 10.1002/mds.28187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
83 Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 2020;91:795-808. [PMID: 32576618 DOI: 10.1136/jnnp-2019-322338] [Cited by in Crossref: 136] [Cited by in F6Publishing: 116] [Article Influence: 68.0] [Reference Citation Analysis]
84 Cardoso T, Lévesque M. Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons in vitro. Front Cell Dev Biol 2020;8:443. [PMID: 32626706 DOI: 10.3389/fcell.2020.00443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Hunyara JL, Kolodkin AL. Repurposing developmental mechanisms in the adult nervous system. Curr Opin Genet Dev 2020;65:14-21. [PMID: 32485480 DOI: 10.1016/j.gde.2020.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 McNeill RV, Ziegler GC, Radtke F, Nieberler M, Lesch KP, Kittel-Schneider S. Mental health dished up-the use of iPSC models in neuropsychiatric research. J Neural Transm (Vienna) 2020;127:1547-68. [PMID: 32377792 DOI: 10.1007/s00702-020-02197-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Osborn TM, Hallett PJ, Schumacher JM, Isacson O. Advantages and Recent Developments of Autologous Cell Therapy for Parkinson's Disease Patients. Front Cell Neurosci 2020;14:58. [PMID: 32317934 DOI: 10.3389/fncel.2020.00058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
88 Adler AF, Björklund A, Parmar M. Transsynaptic tracing and its emerging use to assess graft-reconstructed neural circuits. Stem Cells 2020;38:716-26. [PMID: 32101353 DOI: 10.1002/stem.3166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]